ANTX

NASDAQStock

AN2 Therapeutics, Inc.

$5.18-0.26 (-4.78%)

52-Week Range

$1.03

$5.46

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

-0.03

Volume

517.7K

Avg Volume

5.3M

Performance

+413.21%

+364.96%

+325.00%

YTD

+390.09%

+291.37%

-31.49%

-64.68%

Price Chart

ETF Exposure

ANTX is held by 11 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
GERM	ETFMG Treatments, Testing and Advancements ETF	0.07%	6,614	$7K	$9.7M	0.68%
IWC	iShares Micro-Cap ETF	0.03%	61,829	$315K	$1.27B	0.60%
VALT	ETFMG Sit Ultra Short ETF	0.00%	5,485	$82K	$75.4M	0.30%
SILX	ETFMG Prime 2x Daily Junior Silver Miners ETF	0.00%	6,215	$48K	$5.5M	0.97%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	36	$55	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,288	$2K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	6	$9	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	733,392	$829K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	3,857	$6K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	332	$508	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	201,636	$228K	$84.10B	0.05%

About ANTX ETF Exposure

AN2 Therapeutics, Inc. (ANTX) is held by 11 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $5.18. Investors can gain exposure to ANTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ANTX, sorted by portfolio weight.